Recent advances in ABCG5 and ABCG8 variants

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease

Background:

• Sitosterolemia is a rare genetic disorder characterized by the accumulation of plant sterols (phytosterols) and cholesterol in the blood and tissues.
• Defects in sterol transporters ABCG5 and ABCG8 lead to impaired excretion of dietary and cellular sterols.
• Previously, severe loss-of-function mutations were thought necessary for sitosterolemia, but recent findings suggest a broader spectrum of disease.

Purpose of the Study:

• To review the genetics and mechanisms of sitosterolemia and sterol trafficking.
• To update the understanding of the prevalence of ABCG5 and ABCG8 variants.
• To explore the role of these variants in human disease, particularly cardiovascular risk.

Main Methods:

• Review of existing literature on ABCG5/G8 genetics, sterol metabolism, and clinical studies.
• Analysis of recent case reports and large population studies on variant prevalence.
• Discussion of diagnostic strategies and therapeutic implications.

Main Results:

• Near-complete loss-of-function in ABCG5/G8 is not always required for pathology; heterozygous mutations in both genes can cause sitosterolemia.
• Even simple heterozygous carriers of ABCG5/G8 variants are associated with altered lipid profiles and increased cardiovascular risk.
• The prevalence of ABCG5/G8 variants is higher than previously estimated, especially in hypercholesterolemia patients.

Conclusions:

• Measuring xenosterol levels in hypercholesterolemia patients can aid in screening for ABCG5/G8 variants.
• Tailored treatment with sterol absorption inhibitors like ezetimibe may be indicated for identified patients.
• Dysregulated sterol trafficking impacts remnant clearance and may contribute to atherosclerosis development.